Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy.
Nat Commun
; 13(1): 6357, 2022 10 26.
Article
in En
| MEDLINE
| ID: mdl-36289204
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Optogenetics
/
Neoplasm Recurrence, Local
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom